ArticleCancers2021

Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience.

Daniele Lavacchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.